Keyphrases
Clinical Conditions
100%
Social Security
100%
Raltegravir
100%
Peruvian
100%
Human Immunodeficiency Virus Infection
50%
Clinical Trials
25%
AIDS/HIV
25%
Viral Load
25%
Antiviral Drugs
25%
Retrospective Observational Study
25%
Statistical Software
25%
Integrase Inhibitors
25%
Comorbidity
25%
Qualitative Variables
25%
Arterial Hypertension
25%
Quantitative Variable
25%
CD4 Lymphocytes
25%
Human Immunodeficiency Virus Patients
25%
Type 1 Diabetes Mellitus (T1DM)
25%
Social Insurance
25%
Highly Active Antiretroviral Therapy (HAART)
25%
Low Toxicity
25%
Peru
25%
Male Gender
25%
Lymphocyte Level
25%
Normality Test
25%
Pharmacology, Toxicology and Pharmaceutical Science
Raltegravir
100%
Human Immunodeficiency Virus Infection
50%
HIV
50%
Clinical Trial
25%
Observational Study
25%
Hypertension
25%
Diabetes Mellitus
25%
Integrase Inhibitor
25%
Comorbidity
25%